M.D. Sass LLC purchased a new stake in shares of Flowserve Corporation (NYSE:FLS - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 634,613 shares of the industrial products company's stock, valued at approximately $47,063,000. Flowserve accounts for about 3.1% of M.D. Sass LLC's portfolio, making the stock its 19th biggest position. M.D. Sass LLC owned approximately 0.50% of Flowserve as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. BOKF NA bought a new stake in shares of Flowserve during the third quarter valued at approximately $28,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Flowserve during the second quarter worth $34,000. Atlas Capital Advisors Inc. bought a new position in shares of Flowserve during the fourth quarter worth $36,000. Measured Wealth Private Client Group LLC purchased a new position in Flowserve during the third quarter valued at $36,000. Finally, Global Retirement Partners LLC purchased a new position in Flowserve during the second quarter valued at $38,000. 93.93% of the stock is currently owned by hedge funds and other institutional investors.
Flowserve Stock Performance
Shares of NYSE:FLS opened at $78.98 on Wednesday. The company has a market capitalization of $10.04 billion, a price-to-earnings ratio of 27.71, a PEG ratio of 1.80 and a beta of 1.23. Flowserve Corporation has a 12 month low of $48.71 and a 12 month high of $92.41. The firm's 50-day moving average is $75.01 and its 200 day moving average is $77.16. The company has a current ratio of 2.15, a quick ratio of 1.58 and a debt-to-equity ratio of 0.91.
Flowserve (NYSE:FLS - Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The industrial products company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.86 by $0.09. The business had revenue of $1.17 billion during the quarter, compared to the consensus estimate of $1.16 billion. Flowserve had a net margin of 8.01% and a return on equity of 21.42%. The firm's quarterly revenue was down 1.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.91 earnings per share. Flowserve has set its FY 2026 guidance at 4.050-4.200 EPS. Research analysts predict that Flowserve Corporation will post 4.1 EPS for the current year.
Wall Street Analyst Weigh In
A number of equities research analysts recently commented on the company. Robert W. Baird set a $93.00 target price on Flowserve in a research report on Friday, July 31st. Weiss Ratings raised Flowserve from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Tuesday, August 11th. Royal Bank Of Canada raised their target price on shares of Flowserve from $91.00 to $94.00 and gave the company an "outperform" rating in a report on Friday, July 31st. The Goldman Sachs Group set a $82.00 price target on shares of Flowserve in a research note on Thursday, July 30th. Finally, Wall Street Zen cut shares of Flowserve from a "buy" rating to a "hold" rating in a research report on Saturday, April 25th. Seven investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $86.60.
Check Out Our Latest Stock Analysis on Flowserve
Flowserve Company Profile
(
Free Report)
Flowserve Corporation NYSE: FLS is a leading provider of fluid motion and control products and services. The company designs, manufactures and services engineered and industrial pumps, mechanical seals, valves and related flow management equipment. Flowserve's offerings are utilized across a broad spectrum of end markets, including oil and gas, power generation, chemical processing, water management, pharmaceutical and semiconductor manufacturing, as well as mining and general industrial applications.
Flowserve's product portfolio encompasses a wide range of centrifugal and positive displacement pumps, high-performance control valves, butterfly and ball valves, as well as mechanical seals and seal support systems.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Flowserve, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Flowserve wasn't on the list.
While Flowserve currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
